Company Announcements

RNS Number : 9297T
Immunodiagnostic Systems Hldgs PLC
23 July 2020
 

 

 

 

 

   Results of AGM

 

Immunodiagnostic Systems Holdings PLC 

23 July 2020

Immunodiagnostic Systems Holdings plc 

Results of AGM

Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces the results of its Annual General Meeting (the "Meeting") that was held at 2pm today.

 

Trading Update

 

The Chairman of the Meeting provided a business update and a copy of the statement has been made available on the Company's website.

 

Voting Results

All resolutions put to the Meeting were decided on a show of hands and all were duly passed.

 

For information, details of the proxy voting are shown below:

 

Resolution

Votes For

Votes For (as % of votes cast)

Votes Against (as % of votes cast)

Votes Withheld

1.        To receive the accounts for the year ended 31 March 2020 together with the report of the Directors and of the Auditor thereon.

15,238,341

100.00%

0.00%

0

2.        To declare a final dividend for the year ended 31 March 2020.

15,238,341

100.00%

0.00%

0

3.        To re-appoint Pricewaterhouse-Coopers LLP as Auditor of the Company.

15,238,341

100.00%

0.00%

0

4.        To authorise the Directors of the Company to determine the remuneration of the Auditor of the Company.

15,238,341

100.00%

0.00%

0

5.        To approve the Directors' Remuneration Report for the financial year ended 31 March 2020.

14,436,907

94.75%

5.25%

814

6.        To authorise the Directors to allot relevant securities.

14,437,577

94.75%

5.25%

764

7.        To authorise the disapplication of pre-emption rights in accordance with section 570 of the Companies Act 2006.

14,437,577

94.75%

5.25%

764

8.        To authorise the Directors to make market purchases.

15,238,341

100.00%

0.00%

0

 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).

 

For further information:

 

Immunodiagnostic Systems Holdings plc                               Tel : +44 (0)191 5190660

Paul Martin, Group Finance Director

 

Peel Hunt LLP                                                                                 Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGFLFEVDSIVFII